LENZ Therapeutics’ $30 Million Private Placement Financing

Wilson Sonsini Goodrich & Rosati advised LENZ Therapeutics on the transaction.LENZ Therapeutics (Nasdaq: LENZ), a late clinical-stage biopharmaceutical company, announced that it has entered into a…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now